Skip to main content
Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
5.52
+0.08 (1.47%)
Jun 17, 2025, 11:52 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Relyvrio (Sodium Phenylbutyrate and Taurursodiol)
87.37M
Log In
Log In
Log In
Log In
Upgrade
Relyvrio (Sodium Phenylbutyrate and Taurursodiol) Growth
-77.06%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
87.37M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-77.06%
Log In
Log In
Log In
Log In
Upgrade